Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 4.42B P/E - EPS this Y 32.70% Ern Qtrly Grth -
Income -94.98M Forward P/E 42.83 EPS next Y 131.40% 50D Avg Chg 5.00%
Sales 820.8M PEG -0.09 EPS past 5Y - 200D Avg Chg 24.00%
Dividend N/A Price/Book 3.70 EPS next 5Y 235.60% 52W High Chg -17.00%
Recommedations 2.00 Quick Ratio 1.92 Shares Outstanding 354.37M 52W Low Chg 59.00%
Insider Own - ROA 0.18% Shares Float 145.80M Beta 1.11
Inst Own 1.61% ROE -8.02% Shares Shorted/Prior 74.42K/73.53K Price 12.42
Gross Margin 26.78% Profit Margin -11.57% Avg. Volume 19,138 Target Price 15.60
Oper. Margin -6.20% Earnings Date - Volume 14,591 Change -4.90%
About Evotec SE

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer; Lilly; Almirall; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Janseen Biotech; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals, as well as a strategic partnership with Dewpoint Therapeutics to advance oncology pipeline programs of condensate modifying therapeutics to investigational new drug applications and a licensing agreement with Glycotope GmbH to develop next generation immune cell engaging bispecifics for various potential indications, including solid tumors The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

Evotec SE News
04/18/24 Evotec and Variant Bio Enter Strategic Partnership to Discover and Develop Fibrosis Treatments
04/17/24 Evotec SE to Announce Results for Fiscal Year 2023 on 24 April 2024
04/17/24 Evotec welcomes Aurélie Dalbiez as Chief People Officer
04/12/24 Health Care Roundup: Market Talk
08:44 AM Finding the Next Big Winners: 7 Stocks You Can Snag for Under $10
03/18/24 Evotec (ETR:EVT shareholders incur further losses as stock declines 3.7% this week, taking three-year losses to 59%
03/06/24 3 Stocks Set to Double: Your Fast Track to 2024 Gains
03/06/24 Evotec And Claris Ventures Streamline Access to Accelerate Programmes from Claris's Portfolio Companies into The Clinic
03/04/24 7 Stable Stocks to Buy for 100% Returns by 2025
02/15/24 The Next Johnson & Johnson? 3 Healthcare Stocks That Investors Shouldn’t Ignore.
02/07/24 Just - Evotec Biologics Expands Development and Manufacturing Agreement with ABL for Broadly Neutralising Antibodies Against HIV
01/22/24 Evotec SE: Invitation to Conference Call
01/22/24 UPDATE 1-Evotec says it promptly reported share trades withheld by former CEO
01/10/24 Evotec and Crohn's & Colitis Foundation Enter Agreement to Advance Drug Discovery for Novel IBD Therapies
01/08/24 Evotec Announces Progress in Strategic Neuroscience Partnership with Bristol Myers Squibb
01/04/24 Evotec and Owkin Enter an A.I.-Powered Strategic Partnership to Accelerate Therapeutics Pipeline in Oncology and I&I
01/03/24 Evotec Announces CEO Transition
12/19/23 Evotec receives US$ 2.5 M Grant to Leverage Human iPSC-Derived Teratogenicity Platform for Global Health Programmes
12/14/23 Evotec Enters Partnership with Charité to Expand Molecular Patient Database in Autoimmune Diseases
12/06/23 Evotec-partner Jingxin Receives Approval for EVT201 in China
EVO Chatroom

User Image Stock_Titan Posted - 1 day ago

$EVO EVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS https://www.stocktitan.net/news/EVO/evotec-and-variant-bio-enter-strategic-partnership-to-discover-and-47kzn6jfm4nd.html

User Image DailyStocksPicks Posted - 1 month ago

Oversold Pick #4: $AGL financial underperformance highlighted by a significant earnings miss for Q4 2023 and downward adjustments in future EPS estimates, alongside analyst downgrades and an underweight rating from Barclays makes it oversold. Despite institutional investors like Wellington Management Group LLP and Morgan Stanley increasing their positions, the stock reached a new 52-week low, reflecting market concerns about the company's growth prospects and profitability challenges. Mixed social media sentiment and concerns over the company's cash burn and operational challenges in the Medicare Advantage sector add to the bearish outlook. These elements, combined with strategic management shifts such as the transition of the Chief Medical Officer and widened revenue guidance for FY24, signal uncertainty and contribute to the perception of the stock being oversold. $PGNY, $SHC, $EVO, $ICUI For More Details: https://youtu.be/Ff3pi-Ew5Og

User Image swingingtech Posted - 2 months ago

$JNJ, $CRL, $CLPT, $EVO https://wallstreetwaves.com/the-next-johnson-johnson-3-healthcare-stocks-that-investors-shouldnt-ignore/

User Image cctranscripts Posted - 01/22/24

Reading CEO notes presented in the $EVO earnings call transcript https://conferencecalltranscripts.com/summary/?id=536577&pr=true

User Image tickeron Posted - 01/22/24

Which stock is the best to invest? Compare $EVO vs. $KEN vs. $REI. #EvotecSE https://srnk.us/go/4976096

User Image DonCorleone77 Posted - 01/22/24

$EVO Evotec says Lanthaler failed to report stock trades on time, Bloomberg reports Werner Lanthaler, the former CEO of Evotec, failed to report stock dealings on time, Bloomberg's Ashleigh Furlong and Nicholas Comfort reports. Chairperson Iris Low-Friedrich said on an investor webcast that the stock trades that were reported late took place over the course of three years. Lanthaler unexpectedly stepped down at the beginning of the month. Lanthaler told Bloomberg by phone that the delayed disclosure was a "lapse" and unrelated to his exit.

User Image STCKPRO Posted - 01/22/24

$EVO NEW ARTICLE : Evotec SE: Invitation to Conference Call https://stck.pro/news/EVO/73443114/

User Image tickeron Posted - 01/21/24

$EVO vs. $OIL vs. $REI.X: what is the best stock to add to your portfolio? #EvotecSE https://srnk.us/go/4974895

User Image StockAutomatePro Posted - 3 months ago

$EVO The chart is predicting a rough patch for the stock. We alerted the SELL signal at $9.7 and we were able to close this one with profit at $7.97 💖

User Image tickeron Posted - 3 months ago

What stocks might make more money? Pick the best $EVO vs. $OIL vs. $REI.X. #EvotecSE https://srnk.us/go/4971501

User Image tickeron Posted - 3 months ago

What are the hottest stocks right now? Pick the best $EVO vs. $OIL vs. $REI.X. #EvotecSE https://srnk.us/go/4970131

User Image tickeron Posted - 3 months ago

Which stock is the best to invest? Compare $EVO vs. $OIL vs. $REI.X. #EvotecSE https://srnk.us/go/4970112

User Image tickeron Posted - 3 months ago

What stocks might make more money? Pick the best $EVO vs. $OIL vs. $REI.X. #EvotecSE https://srnk.us/go/4967945

User Image Stock_Titan Posted - 3 months ago

$EVTCY $EVO Evotec and Crohn's & Colitis Foundation Enter Agreement to Advance Drug Discovery for Novel IBD Therapies

User Image Stock_Titan Posted - 3 months ago

$EVOTF $EVO Evotec Announces Progress in Strategic Neuroscience Partnership with Bristol Myers Squibb

User Image tickeron Posted - 3 months ago

What are the hottest stocks right now? Pick the best $EVO vs. $OIL vs. $REI.X. #EvotecSE https://srnk.us/go/4962879

User Image tickeron Posted - 3 months ago

$EVO vs. $OIL vs. $REI.X: which stock is the best to buy? #EvotecSE https://srnk.us/go/4960694

User Image tickeron Posted - 3 months ago

$EVO vs. $OIL vs. $REI.X: what will be the best investment? #EvotecSE https://srnk.us/go/4960669

User Image InvestorPlace Posted - 3 months ago

Here's why $EVO is down today! https://investorplace.com/2024/01/why-is-evotec-evo-stock-down-12-today/

User Image swingingtech Posted - 3 months ago

$CALM $MTC $EVO $DYN https://wallstreetwaves.com/cal-maine-posts-downbeat-q2-results-joins-dyne-therapeutics-opko-health-and-other-big-stoc

User Image EarningsInsider Posted - 3 months ago

$EVO updates FY 2023 guidance to EPS and revenue guidance to $816.3 million-$859.9 million. www.marketbeat.com/stocks/NASDAQ/EVO/earnings/

User Image Stock_Titan Posted - 3 months ago

$EVTCY $EVO Evotec and Owkin Enter an A.I.-Powered Strategic Partnership to Accelerate Therapeutics Pipeline in Oncology and I&I

User Image Stock_Titan Posted - 3 months ago

$EVTCY $EVO Evotec Announces CEO Transition

User Image tickeron Posted - 3 months ago

$EVO vs. $OIL vs. $REI.X: what is the best stock to add to your portfolio? #EvotecSE https://srnk.us/go/4958193

User Image tickeron Posted - 3 months ago

Which stock is the best to invest? Compare $EVO vs. $OIL vs. $REI.X. #EvotecSE https://srnk.us/go/4957269

User Image tickeron Posted - 3 months ago

Which stock is the best to invest? Compare $EVO vs. $OIL vs. $REI.X. #EvotecSE https://srnk.us/go/4957265

User Image tickeron Posted - 12/31/23

$EVO vs. $OIL vs. $REI.X: what will be the best investment? #EvotecSE https://srnk.us/go/4956247

User Image Stock_Titan Posted - 4 months ago

$EVTCY $EVO Evotec receives US$ 2.5 M Grant to Leverage Human iPSC-Derived Teratogenicity Platform for Global Health Programmes Article Available on StockTitan Website.

User Image dividendinvestorbyeagle Posted - 4 months ago

$EVO close increased > 10% (ADS (Sponsored)/Evotec SE) https://www.dividendinvestor.com/dividend-news/?symbol=evo http://dlvr.it/T0CFf4

User Image dividendinvestorbyeagle Posted - 4 months ago

$EVO close increased > 10% (ADS (Sponsored)/Evotec SE) https://www.dividendinvestor.com/dividend-news/?symbol=evo http://dlvr.it/T0CBjq

Analyst Ratings
HC Wainwright & Co. Buy Aug 31, 23
HC Wainwright & Co. Buy Jul 12, 23
Morgan Stanley Overweight Jun 23, 23
B of A Securities Neutral Jun 16, 23
Citigroup Buy Jun 8, 23
Morgan Stanley Equal-Weight Apr 4, 23
HC Wainwright & Co. Buy Mar 29, 23
HC Wainwright & Co. Buy Jan 27, 23
HC Wainwright & Co. Buy Dec 9, 22